Janux Therapeutics Inc (JANX)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 1.41B
P/E Ratio
0.00
Revenue (TTM)
$ 439K
Volume
0
52W High
$ 71.71
52W Low
$ 21.97
Dividend Yield
0.00%
Beta
2.84
Technicals
50-Day MA
24.5637
200-Day MA
32.8078
52 Week High
71.71
52 Week Low
21.971
About JANX
Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms t.
Employees
103
Headquarters
San Diego, CA
CEO
Dr. David Alan Campbell Ph.D.